Literature DB >> 31611073

Class I phosphoinositide 3-kinase (PI3K) regulatory subunits and their roles in signaling and disease.

Manoj K Rathinaswamy1, John E Burke2.   

Abstract

The Class I phosphoinositide 3-kinases (PI3Ks) are a group of heterodimeric lipid kinases that regulate crucial cellular processes including proliferation, survival, growth, and metabolism. The diversity in functions controlled by the various catalytic isoforms (p110α, p110β, p110δ, and p110γ) depends on their abilities to be activated by distinct stimuli such as receptor tyrosine kinases (RTKs), G-protein coupled receptors (GPCRs), and the Ras family of small G-proteins. A major factor determining the ability of each p110 enzyme to be activated is the presence of regulatory binding partners. Given the overwhelming evidence for the involvement of PI3Ks in diseases such as cancer, inflammation, immunodeficiency and diabetes, an understanding of how these regulatory proteins influence PI3K function is essential. This article highlights research deciphering the role of regulatory subunits in PI3K signaling and their involvement in human disease.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  PI3K; PIK3CA; PIK3R1; Phosphoinositide 3-kinase; p110; p85

Mesh:

Substances:

Year:  2019        PMID: 31611073     DOI: 10.1016/j.jbior.2019.100657

Source DB:  PubMed          Journal:  Adv Biol Regul        ISSN: 2212-4926


  18 in total

1.  PI3K and AKT at the Interface of Signaling and Metabolism.

Authors:  Giovanni Solinas; Barbara Becattini
Journal:  Curr Top Microbiol Immunol       Date:  2022       Impact factor: 4.737

2.  CircHIPK3/miR-876-5p/PIK3R1 axis regulates regulation proliferation, migration, invasion, and glutaminolysis in gastric cancer cells.

Authors:  Qingchun Li; Yuan Tian; Yun Liang; Chang Li
Journal:  Cancer Cell Int       Date:  2020-08-13       Impact factor: 5.722

Review 3.  Ras, PI3K and mTORC2 - three's a crowd?

Authors:  Stephen F Smith; Shannon E Collins; Pascale G Charest
Journal:  J Cell Sci       Date:  2020-10-08       Impact factor: 5.285

4.  The G-Protein Rab5A Activates VPS34 Complex II, a Class III PI3K, by a Dual Regulatory Mechanism.

Authors:  Thomas C Buckles; Yohei Ohashi; Shirley Tremel; Stephen H McLaughlin; Els Pardon; Jan Steyaert; Moshe T Gordon; Roger L Williams; Joseph J Falke
Journal:  Biophys J       Date:  2020-10-31       Impact factor: 4.033

Review 5.  "Modulating Phosphoinositide Profiles as a Roadmap for Treatment in Acute Myeloid Leukemia".

Authors:  Stefano Ratti; Camilla Evangelisti; Sara Mongiorgi; Alessia De Stefano; Antonietta Fazio; Francesca Bonomini; Matilde Y Follo; Irene Faenza; Lucia Manzoli; Bhavwanti Sheth; Magdalena C Vidalle; Scott T Kimber; Nullin Divecha; Lucio Cocco; Roberta Fiume
Journal:  Front Oncol       Date:  2021-05-24       Impact factor: 6.244

Review 6.  The role of PI3Kγ in the immune system: new insights and translational implications.

Authors:  Stephen M Lanahan; Matthias P Wymann; Carrie L Lucas
Journal:  Nat Rev Immunol       Date:  2022-03-23       Impact factor: 53.106

Review 7.  mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer.

Authors:  Karen Griselda de la Cruz López; Mariel Esperanza Toledo Guzmán; Elizabeth Ortiz Sánchez; Alejandro García Carrancá
Journal:  Front Oncol       Date:  2019-12-13       Impact factor: 6.244

8.  miR-100-3p inhibits the adipogenic differentiation of hMSCs by targeting PIK3R1 via the PI3K/AKT signaling pathway.

Authors:  Tao Wang; Donghuo Zhong; Zhongjun Qin; Shan He; Ying Gong; Weidong Li; Xingnuan Li
Journal:  Aging (Albany NY)       Date:  2020-11-20       Impact factor: 5.682

9.  Study of the active ingredients and mechanism of Sparganii rhizoma in gastric cancer based on HPLC-Q-TOF-MS/MS and network pharmacology.

Authors:  Xiaona Lu; Yawei Zheng; Fang Wen; Wenjie Huang; Xiaoxue Chen; Shuai Ruan; Suping Gu; Yue Hu; Yuhao Teng; Peng Shu
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

10.  Investigating potential molecular mechanisms of serum exosomal miRNAs in colorectal cancer based on bioinformatics analysis.

Authors:  Haifeng Wang; Xiliang Chen; Lingling Bao; Xuede Zhang
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.